Rationale for a novel nutraceutical complex 'K-water': Potassium taurine bicarbonate (PTB)

Medical Hypotheses

Volumn 67, Issue 1, 2006, Pages 65-70

  McCarty, Mark F ^a  

^a Natural Alternatives International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM BICARBONATE; POTASSIUM TAURINE BICARBONATE; TAURINE; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; BONE DENSITY; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIET SUPPLEMENTATION; HUMAN; NEPHROLITHIASIS; PRIORITY JOURNAL; STROKE; THROMBOEMBOLISM; WEIGHT GAIN;

ANIMALS; ATHEROSCLEROSIS; BICARBONATES; BLOOD PRESSURE; DIETARY SUPPLEMENTS; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; MODELS, BIOLOGICAL; NUTRITIONAL REQUIREMENTS; POTASSIUM COMPOUNDS; TAURINE; THROMBOEMBOLISM; WATER;

EID: 33646085536     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.09.056     Document Type: Article

References (94)

1. Frassetto L., Morris R.C.J., Sellmeyer D.E., Todd K., and Sebastian A. Diet, evolution and aging - the pathophysiologic effects of the post-agricultural inversion of the potassium-to-sodium and base-to-chloride ratios in the human diet. Eur J Nutr 40 (2001) 200-223
2. Smith S.J., Markandu N.D., Sagnella G.A., and MacGregor G.A. Moderate potassium chloride supplementation in essential hypertension: is it additive to moderate sodium restriction?. Br Med J (Clin Res Ed) 290 (1985) 110-113
3. Cappuccio F.P., and MacGregor G.A. Does potassium supplementation lower blood pressure? A meta-analysis of published trials. J Hypertens 9 (1991) 465-473
4. Whelton P.K., He J., Cutler J.A., Brancati F.L., Appel L.J., Follmann D., et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 277 (1997) 1624-1632
5. Khaw K.T., and Barrett-Connor E. Dietary potassium and stroke-associated mortality. A 12-year prospective population study. New Engl J Med 316 (1987) 235-240
6. Suter P.M. The effects of potassium, magnesium, calcium, and fiber on risk of stroke. Nutr Rev 57 (1999) 84-88
7. Iso H., Stampfer M.J., Manson J.E., Rexrode K., Hennekens C.H., Colditz G.A., et al. Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke 30 (1999) 1772-1779
8. Fang J., Madhavan S., and Alderman M.H. Dietary potassium intake and stroke mortality. Stroke 31 (2000) 1532-1537
9. Bazzano L.A., He J., Ogden L.G., Loria C., Vupputuri S., Myers L., et al. Dietary potassium intake and risk of stroke in US men and women: National Health and Nutrition Examination Survey I epidemiologic follow-up study. Stroke 32 (2001) 1473-1480
10. Law M.R., and Morris J.K. By how much does fruit and vegetable consumption reduce the risk of ischaemic heart disease?. Eur J Clin Nutr 52 (1998) 549-556
11. Joshipura K.J., Hu F.B., Manson J.E., Stampfer M.J., Rimm E.B., Speizer F.E., et al. The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med 134 (2001) 1106-1114
12. Dietz R. The role of potassium in hypertension. Discovery of potassium as a natriuretic and antihypertensive agent. Am J Nephrol 3 (1983) 100-108
13. Smith S.R., Klotman P.E., and Svetkey L.P. Potassium chloride lowers blood pressure and causes natriuresis in older patients with hypertension. J Am Soc Nephrol 2 (1992) 1302-1309
14. Krishna G.G., and Kapoor S.C. Potassium supplementation ameliorates mineralocorticoid-induced sodium retention. Kidney Int 43 (1993) 1097-1103
15. Zhou M.S., Nishida Y., Yoneyama H., Chen Q.H., and Kosaka H. Potassium supplementation increases sodium excretion and nitric oxide production in hypertensive Dahl rats. Clin Exp Hypertens 21 (1999) 1397-1411
16. McCabe R.D., Bakarich M.A., Srivastava K., and Young D.B. Potassium inhibits free radical formation. Hypertension 24 (1994) 77-82
17. Young D.B., Lin H., and McCabe R.D. Potassium's cardiovascular protective mechanisms. Am J Physiol 268 (1995) R825-R837
18. McCarty M.F. Endothelial membrane potential regulates production of both nitric oxide and superoxide-a fundamental determinant of vascular health. Med Hypotheses 53 (1999) 277-289
19. Cappuccio F.P., Kalaitzidis R., Duneclift S., and Eastwood J.B. Unravelling the links between calcium excretion, salt intake, hypertension, kidney stones and bone metabolism. J Nephrol 13 (2000) 169-177
20. Lemann J.J., Pleuss J.A., Gray R.W., and Hoffmann R.G. Potassium administration reduces and potassium deprivation increases urinary calcium excretion in healthy adults [corrected]. Kidney Int 39 (1991) 973-983
21. Lemann J.J., Pleuss J.A., and Gray R.W. Potassium causes calcium retention in healthy adults. J Nutr 123 (1993) 1623-1626
22. Lemann J.J., Pleuss J.A., Hornick L., and Hoffman R.G. Dietary NaCl-restriction prevents the calciuria of KCl-deprivation and blunts the calciuria of KHCO3-deprivation in healthy adults. Kidney Int 47 (1995) 899-906
23. Wasserstein A.G., Stolley P.D., Soper K.A., Goldfarb S., Maislin G., and Agus Z. Case-control study of risk factors for idiopathic calcium nephrolithiasis. Miner Electrolyte Metab 13 (1987) 85-95
24. Hall W.D., Pettinger M., Oberman A., Watts N.B., Johnson K.C., Paskett E.D., et al. Risk factors for kidney stones in older women in the southern United States. Am J Med Sci 322 (2001) 12-18
25. Antonios T.F., and MacGregor G.A. Deleterious effects of salt intake other than effects on blood pressure. Clin Exp Pharmacol Physiol 22 (1995) 180-184
26. Wachman A., and Bernstein D.S. Diet and osteoporosis. Lancet 1 (1968) 958-959
27. Frassetto L.A., Todd K.M., Morris R.C.J., and Sebastian A. Worldwide incidence of hip fracture in elderly women: relation to consumption of animal and vegetable foods. J Gerontol A Biol Sci Med Sci 55 (2000) M585-M592
28. Sellmeyer D.E., Stone K.L., Sebastian A., and Cummings S.R. A high ratio of dietary animal to vegetable protein increases the rate of bone loss and the risk of fracture in postmenopausal women. Study of Osteoporotic Fractures Research Group. Am J Clin Nutr 73 (2001) 118-122
29. New S.A., Bolton-Smith C., Grubb D.A., and Reid D.M. Nutritional influences on bone mineral density: a cross-sectional study in premenopausal women. Am J Clin Nutr 65 (1997) 1831-1839
30. Tucker K.L., Hannan M.T., Chen H., Cupples L.A., Wilson P.W., and Kiel D.P. Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr 69 (1999) 727-736
31. New S.A., Robins S.P., Campbell M.K., Martin J.C., Garton M.J., Bolton-Smith C., et al. Dietary influences on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health. Am J Clin Nutr 71 (2000) 142-151
32. Sebastian A., and Morris R.C.J. Improved mineral balance and skeletal metabolism in postmenopausal women treated with potassium bicarbonate. New Engl J Med 331 (1994) 279 Sebastian, A
33. Morris R.C.J., Schmidlin O., Tanaka M., Forman A., Frassetto L., and Sebastian A. Differing effects of supplemental KCl and KHCO3: pathophysiological and clinical implications. Semin Nephrol 19 (1999) 487-493
34. Sellmeyer D.E., Schloetter M., and Sebastian A. Potassium citrate prevents increased urine calcium excretion and bone resorption induced by a high sodium chloride diet. J Clin Endocrinol Metab 87 (2002) 2008-2012
35. Pak C.Y., Peterson R.D., and Poindexter J. Prevention of spinal bone loss by potassium citrate in cases of calcium urolithiasis. J Urol 168 (2002) 31-34
36. Rodman J.S. Prophylaxis of uric acid stones with alternate day doses of alkaline potassium salts. J Urol 145 (1991) 97-99
37. Welbourne T.C. Acidosis activation of the pituitary-adrenal-renal glutaminase I axis. Endocrinology 99 (1976) 1071-1079
38. Welbourne T.C., and Francoeur D. Influence of aldosterone on renal ammonia production. Am J Physiol 233 (1977) E56-E60
39. Perez G.O., Oster J.R., Katz F.H., and Vaamonde C.A. The effect of acute metabolic acidosis on plasma cortisol, renin activity and aldosterone. Horm Res 11 (1979) 12-21
40. Henger A., Tutt P., Riesen W.F., Hulter H.N., and Krapf R. Acid-base and endocrine effects of aldosterone and angiotensin II inhibition in metabolic acidosis in human patients. J Lab Clin Med 136 (2000) 379-389
41. Colditz G.A., Manson J.E., Stampfer M.J., Rosner B., Willett W.C., and Speizer F.E. Diet and risk of clinical diabetes in women. Am J Clin Nutr 55 (1992) 1018-1023
42. McCarty M.F. Acid-base balance may influence risk for insulin resistance syndrome by modulating cortisol output. Med Hypotheses 64 (2005) 380-384
43. Frassetto L., Morris Jr. R.C., and Sebastian A. Potassium bicarbonate reduces urinary nitrogen excretion in postmenopausal women. J Clin Endocrinol Metab 82 (1997) 254-259
44. Maurer M., Riesen W., Muser J., Hulter H.N., and Krapf R. Neutralization of Western diet inhibits bone resorption independently of K intake and reduces cortisol secretion in humans. Am J Physiol Renal Physiol 284 (2003) F32-F40
45. Wang X.B., and Zhao X.H. The effect of dietary sulfur-containing amino acids on calcium excretion. Adv Exp Med Biol 442 (1998) 495-499
46. Hayes K.C., Pronczuk A., Addesa A.E., and Stephan Z.F. Taurine modulates platelet aggregation in cats and humans. Am J Clin Nutr 49 (1989) 1211-1216
47. Franconi F., Bennardini F., Mattana A., Miceli M., Ciuti M., Mian M., et al. Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation. Am J Clin Nutr 61 (1995) 1115-1119
48. Franconi F., Miceli M., Bennardini F., Mattana A., Covarrubias J., and Seghieri G. Taurine potentiates the antiaggregatory action of aspirin and indomethacin. Adv Exp Med Biol 315 (1992) 181-186
49. Kohashi N., Okabayashi T., Hama J., and Katori R. Decreased urinary taurine in essential hypertension. Prog Clin Biol Res 125 (1983) 73-87
50. Fujita T., Ando K., Noda H., Ito Y., and Sato Y. Effects of increased adrenomedullary activity and taurine in young patients with borderline hypertension. Circulation 75 (1987) 525-532
51. Yamori Y., Nara Y., Ikeda K., and Mizushima S. Is taurine a preventive nutritional factor of cardiovascular diseases or just a biological marker of nutrition?. Adv Exp Med Biol 403 (1996) 623-629
52. Nara Y., Yamori Y., and Lovenberg W. Effect of dietary taurine on blood pressure in spontaneously hypertensive rats. Biochem Pharmacol 27 (1978) 2689-2692
53. Sato Y., Ogata E., and Fujita T. Hypotensive action of taurine in DOCA-salt rats - involvement of sympathoadrenal inhibition and endogenous opiate. Jpn Circ J 55 (1991) 500-508
54. Ideishi M., Miura S., Sakai T., Sasaguri M., Misumi Y., and Arakawa K. Taurine amplifies renal kallikrein and prevents salt-induced hypertension in Dahl rats. J Hypertens 12 (1994) 653-661
55. Anuradha C.V., and Balakrishnan S.D. Taurine attenuates hypertension and improves insulin sensitivity in the fructose-fed rat, an animal model of insulin resistance. Can J Physiol Pharmacol 77 (1999) 749-754
56. Harada H., Kitazaki K., Tsujino T., Watari Y., Iwata S., Nonaka H., et al. Oral taurine supplementation prevents the development of ethanol-induced hypertension in rats. Hypertens Res 23 (2000) 277-284
57. Petty M.A., Kintz J., and DiFrancesco G.F. The effects of taurine on atherosclerosis development in cholesterol-fed rabbits. Eur J Pharmacol 180 (1990) 119-127
58. Kondo Y., Murakami S., Oda H., and Nagate T. Taurine reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. Adv Exp Med Biol 483 (2000) 193-202
59. Murakami S., Kondo Y., Sakurai T., Kitajima H., and Nagate T. Taurine suppresses development of atherosclerosis in Watanabe heritable hyperlipidemic (WHHL) rabbits. Atherosclerosis 163 (2002) 79-87
60. Azuma J., Sawamura A., Awata N., Ohta H., Hamaguchi T., Harada H., et al. Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial. Clin Cardiol 8 (1985) 276-282
61. Azuma J., Sawamura A., and Awata N. Usefulness of taurine in chronic congestive heart failure and its prospective application. Jpn Circ J 56 (1992) 95-99
62. Azuma J., Takihara K., Awata N., Ohta H., Sawamura A., Harada H., et al. Beneficial effect of taurine on congestive heart failure induced by chronic aortic regurgitation in rabbits. Res Commun Chem Pathol Pharmacol 45 (1984) 261-270
63. McCarty M.F. The reported clinical utility of taurine in ischemic disorders may reflect a down-regulation of neutrophil activation and adhesion. Med Hypotheses 53 (1999) 290-299
64. Wright C.E., Lin T.T., Lin Y.Y., Sturman J.A., and Gaull G.E. Taurine scavenges oxidized chlorine in biological systems. Prog Clin Biol Res 179 (1985) 137-147
65. Nikpoor B., Turecki G., Fournier C., Theroux P., and Rouleau G.A. A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. Am Heart J 142 (2001) 336-339
66. Hazell L.J., Arnold L., Flowers D., Waeg G., Malle E., and Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest 97 (1996) 1535-1544
67. Hazell L.J., Baernthaler G., and Stocker R. Correlation between intima-to-media ratio, apolipoprotein B-100, myeloperoxidase, and hypochlorite-oxidized proteins in human atherosclerosis. Free Radic Biol Med 31 (2001) 1254-1262
68. Hazell L.J., and Stocker R. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem J 290 Pt 1 (1993) 165-172
69. Hazell L.J., Davies M.J., and Stocker R. Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOCl-induced lipid peroxidation of low-density lipoproteins. Biochem J 339 Pt 3 (1999) 489-495
70. Jerlich A., Fritz G., Kharrazi H., Hammel M., Tschabuschnig S., Glatter O., et al. Comparison of HOCl traps with myeloperoxidase inhibitors in prevention of low density lipoprotein oxidation. Biochim Biophys Acta 1481 (2000) 109-118
71. Morel D.W., Llera-Moya M., and Friday K.E. Treatment of cholesterol-fed rabbits with dietary vitamins E and C inhibits lipoprotein oxidation but not development of atherosclerosis. J Nutr 124 (1994) 2123-2130
72. Fruebis J., Carew T.E., and Palinski W. Effect of vitamin E on atherogenesis in LDL receptor-deficient rabbits. Atherosclerosis 117 (1995) 217-224
73. Jacobsson L.S., Yuan X.M., Zieden B., and Olsson A.G. Effects of alpha-tocopherol and astaxanthin on LDL oxidation and atherosclerosis in WHHL rabbits. Atherosclerosis 173 (2004) 231-237
74. Pruthi S., Allison T.G., and Hensrud D.D. Vitamin E supplementation in the prevention of coronary heart disease. Mayo Clin Proc 76 (2001) 1131-1136
75. Marchioli R., Schweiger C., Levantesi G., Tavazzi L., and Valagussa F. Antioxidant vitamins and prevention of cardiovascular disease: epidemiological and clinical trial data. Lipids 36 Suppl. (1902) S53-S63
76. Fu X., Kassim S.Y., Parks W.C., and Heinecke J.W. Hypochlorous acid oxygenates the cysteine switch domain of pro-matri. A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidaselysin (MMP-7). J Biol Chem 276 (2001) 41279-41287
77. McCarty M.F. Supplementary taurine may stabilize atheromatous plaque by antagonizing the activation of metalloproteinases by hypochlorous acid. Med Hypotheses 63 (2004) 414-418
78. Barua M., Liu Y., and Quinn M.R. Taurine chloramine inhibits inducible nitric oxide synthase and TNF-alpha gene expression in activated alveolar macrophages: decreased NF-kappaB activation and IkappaB kinase activity. J Immunol 167 (2001) 2275-2281
79. Kanayama A., Inoue J., Sugita-Konishi Y., Shimizu M., and Miyamoto Y. Oxidation of Ikappa Balpha at methionine 45 is one cause of taurine chloramine-induced inhibition of NF-kappa B activation. J Biol Chem 277 (2002) 24049-24056
80. Hansen S.H. The role of taurine in diabetes and the development of diabetic complications. Diabetes Metab Res Rev 17 (2001) 330-346
81. Pop-Busui R., Sullivan K.A., Van Huysen C., Bayer L., Cao X., Towns R., et al. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits. Exp Neurol 168 (2001) 259-272
82. Trachtman H., Futterweit S., Maesaka J., Ma C., Valderrama E., Fuchs A., et al. Taurine ameliorates chronic streptozocin-induced diabetic nephropathy in rats. Am J Physiol 269 (1995) F429-F438
83. Koide M., Okahashi N., Tanaka R., Kazuno K., Shibasaki K., Yamazaki Y., et al. Inhibition of experimental bone resorption and osteoclast formation and survival by 2-aminoethanesulphonic acid. Arch Oral Biol 44 (1999) 711-719
84. Saransaari P., and Oja S.S. Mechanisms of ischemia-induced taurine release in mouse hippocampal slices. Brain Res 807 (1998) 118-124
85. Saransaari P., and Oja S.S. Taurine and neural cell damage. Amino Acids 19 (2000) 509-526
86. Bureau M.H., and Olsen R.W. Taurine acts on a subclass of GABAA receptors in mammalian brain in vitro. Eur J Pharmacol 207 (1991) 9-16
87. Zhao P., Huang Y.L., and Cheng J.S. Taurine antagonizes calcium overload induced by glutamate or chemical hypoxia in cultured rat hippocampal neurons. Neurosci Lett 268 (1999) 25-28
88. O'Byrne M.B., and Tipton K.F. Taurine-induced attenuation of MPP+ neurotoxicity in vitro: a possible role for the GABA(A) subclass of GABA receptors. J Neurochem 74 (2000) 2087-2093
89. Louzada P.R., Lima A.C., Mendonca-Silva D.L., Noel F., De Mello F.G., and Ferreira S.T. Taurine prevents the neurotoxicity of beta-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders. FASEB J 18 (2004) 511-518
90. Dawson Jr. R., Liu S., Eppler B., and Patterson T. Effects of dietary taurine supplementation or deprivation in aged male Fischer 344 rats. Mech Ageing Dev 107 (1999) 73-91
91. Rivas-Arancibia S., Rodriguez A.I., Zigova T., Willing A.E., Brown W.D., Cahill D.W., et al. Taurine increases rat survival and reduces striatal damage caused by 3-nitropropionic acid. Int J Neurosci 108 (2001) 55-67
92. Guo J., Li R., Zhao P., and Cheng J. Effect of taurine in combination with electroacupuncture on neuronal damage following transient focal cerebral ischemia in rats. Acupunct Electrother Res 27 (2002) 129-136
93. Shuaib A. The role of taurine in cerebral ischemia: studies in transient forebrain ischemia and embolic focal ischemia in rodents. Adv Exp Med Biol 526 (2003) 421-431
94. McCarty M.F. Sub-optimal taurine status may promote platelet hyperaggregability in vegetarians. Med Hypotheses 63 (2004) 426-433